Literature DB >> 9724637

A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression.

R Utrera1, L Collavin, D Lazarević, D Delia, C Schneider.   

Abstract

Wild-type (wt) p53 can act as a sequence-specific transcriptional activator and it is believed that p53 elicits at least part of its biological effects by regulating the expression of specific target genes. By using a differential subtractive hybridization approach in a murine cell line stably transfected with a temperature-sensitive p53 mutant (Val135), we isolated a set of genes markedly induced by wt p53. One of them, provisionally named B99, was further characterized; its transcriptional induction was dependent on wt p53 function and the corresponding protein product was shown to accumulate after DNA damage in different cell types. Immunofluorescence analysis located the B99 protein to the microtubule network. Flow cytometry revealed that upon activation of p53 function the endogenous B99 protein was selectively induced in the G2 fraction of the cell population. When B99 was ectopically expressed in p53-null murine fibroblasts, B99-transfected cells displayed an increased fraction with a 4N DNA content, indicative of interference with G2 phase progression. Taken together these data suggest that B99 might play a role in mediating specific biological activities of wt p53 during the G2 phase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724637      PMCID: PMC1170829          DOI: 10.1093/emboj/17.17.5015

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  43 in total

1.  Increased and altered DNA binding of human p53 by S and G2/M but not G1 cyclin-dependent kinases.

Authors:  Y Wang; C Prives
Journal:  Nature       Date:  1995-07-06       Impact factor: 49.962

2.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.

Authors:  K F Macleod; N Sherry; G Hannon; D Beach; T Tokino; K Kinzler; B Vogelstein; T Jacks
Journal:  Genes Dev       Date:  1995-04-15       Impact factor: 11.361

3.  Gas1-induced growth suppression requires a transactivation-independent p53 function.

Authors:  G Del Sal; E M Ruaro; R Utrera; C N Cole; A J Levine; C Schneider
Journal:  Mol Cell Biol       Date:  1995-12       Impact factor: 4.272

4.  Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein.

Authors:  P Sabbatini; S K Chiou; L Rao; E White
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

5.  A p53-dependent mouse spindle checkpoint.

Authors:  S M Cross; C A Sanchez; C A Morgan; M K Schimke; S Ramel; R L Idzerda; W H Raskind; B J Reid
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

6.  Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.

Authors:  Y Li; C W Jenkins; M A Nichols; Y Xiong
Journal:  Oncogene       Date:  1994-08       Impact factor: 9.867

7.  p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts.

Authors:  M L Agarwal; A Agarwal; W R Taylor; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

8.  Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.

Authors:  C Deng; P Zhang; J W Harper; S J Elledge; P Leder
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

9.  Radiation-induced cell cycle arrest compromised by p21 deficiency.

Authors:  J Brugarolas; C Chandrasekaran; J I Gordon; D Beach; T Jacks; G J Hannon
Journal:  Nature       Date:  1995-10-12       Impact factor: 49.962

10.  Cyclin B interaction with microtubule-associated protein 4 (MAP4) targets p34cdc2 kinase to microtubules and is a potential regulator of M-phase microtubule dynamics.

Authors:  K Ookata; S Hisanaga; J C Bulinski; H Murofushi; H Aizawa; T J Itoh; H Hotani; E Okumura; K Tachibana; T Kishimoto
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  31 in total

1.  The KEN box: an APC recognition signal distinct from the D box targeted by Cdh1.

Authors:  C M Pfleger; M W Kirschner
Journal:  Genes Dev       Date:  2000-03-15       Impact factor: 11.361

2.  Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating Cdh1.

Authors:  C M Pfleger; A Salic; E Lee; M W Kirschner
Journal:  Genes Dev       Date:  2001-07-15       Impact factor: 11.361

3.  Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex.

Authors:  C M Pfleger; E Lee; M W Kirschner
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

4.  Expanding applications of chemical genetics in signal transduction.

Authors:  Scott M Carlson; Forest M White
Journal:  Cell Cycle       Date:  2012-05-15       Impact factor: 4.534

5.  Effects of ginsenoside Rg2 on the ultraviolet B-induced DNA damage responses in HaCaT cells.

Authors:  Se Eun Ha; Dae Hyun Shin; Hyung Do Kim; Sun Mi Shim; Hack Soo Kim; Bo Hyeon Kim; Jung Sup Lee; Jong Kun Park
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-05-28       Impact factor: 3.000

6.  Polo-like kinase 1 phosphorylation of G2 and S-phase-expressed 1 protein is essential for p53 inactivation during G2 checkpoint recovery.

Authors:  X Shawn Liu; Hongchang Li; Bing Song; Xiaoqi Liu
Journal:  EMBO Rep       Date:  2010-06-25       Impact factor: 8.807

7.  Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C.

Authors:  C Scotto; C Delphin; J C Deloulme; J Baudier
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

8.  Mechanisms of G2 arrest in response to overexpression of p53.

Authors:  W R Taylor; S E DePrimo; A Agarwal; M L Agarwal; A H Schönthal; K S Katula; G R Stark
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

9.  Human GTSE-1 regulates p21(CIP1/WAF1) stability conferring resistance to paclitaxel treatment.

Authors:  Débora Rosa Bublik; Massimiliano Scolz; Gianluca Triolo; Martín Monte; Claudio Schneider
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

10.  Quantitative proteomics combined with BAC TransgeneOmics reveals in vivo protein interactions.

Authors:  Nina C Hubner; Alexander W Bird; Jürgen Cox; Bianca Splettstoesser; Peter Bandilla; Ina Poser; Anthony Hyman; Matthias Mann
Journal:  J Cell Biol       Date:  2010-05-17       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.